In Vitro Evaluation of the Percutaneous Absorption of Diclofenac Sodium in Medisca VersaPro Gel Base | Diclofenac Sodium | VersaPro Gel Base | |
Development and Validation of HPLC Assay Method for Stability Testing of a High-Potency Diclofenac Sodium Gel | Diclofenac Sodium | VersaPro Gel Base | |
Stability Assessment of Compounded Bracketed Diclofenac Sodium 1-15% in Medisca VersaPro Gel Base | Diclofenac Sodium | VersaPro Gel Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Gel Base | Testosterone | VersaPro Gel Base | |
In Vitro Evaluation of the Percutaneous Absorption of Ketoprofen, Diclofenac Sodium and Lidocaine Hydrochloride in Medisca VersaPro™ Cream Base and Medisca VersaPro Gel Base | Ketoprofen, Diclofenac Sodium, Lidocaine Hydrochloride | VersaPro Cream Base, VersaPro Gel Base | |
Stability Assessment of Compounded Benzocaine 20%, Lidocaine 6% and Tetracaine 4% in Medisca VersaPro Cream Base | Benzocaine, Lidocaine, Tetracaine | VersaPro Cream Base | |
Stability Assessment of Compounded Cyclobenzaprine Hydrochloride 5%, Diclofenac Sodium 10% and Lidocaine 5% in Medisca VersaPro Cream Base | Cyclobenzaprine Hydrochloride, Diclofenac Sodium, Lidocaine | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Estradiol 0.01-0.2%, Estriol 0.04-0.8%, Progesterone 1-20%, Testosterone 0.025-0.5% and DHEA 0.2-4% in Medisca VersaPro Cream Base | Estradiol, Estriol, Progesterone, Testosterone, DHEA | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Estradiol 0.01-10% in Medisca VersaPro Cream Base | Estradiol | VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.25%, Estriol 0.025-0.25% and Testosterone 1-10% in Medisca VersaPro Cream Base | Estradiol, Estriol, Testoterone | VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5%, Estriol 0.025-0.5% and Progesterone 1-20% in Medisca VersaPro Cream Base | Estradiol, Estriol, Progesterone | VersaPro Cream Base | |
Feasibility Study of Asthma Cream | N/A | VersaPro Cream Base | |
In Vitro Evaluation of the Percutaneous Absorption of Progesterone in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Chemical Stability of Hydrocortisone in Topical Preparation in Proprietary VersaPro Cream Base (potency-over-time only) | Hydrocortisone | VersaPro Cream Base | |
Ninety Day Chemical Stability of Compounded Estradiol, Estrone and Estriol Combination and Beyond Use Date (potency-over-time only) | Estradiol, Estriol, Estrone | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca VersaPro Cream Base | Progesterone | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Diclofenac Sodium 1-15% in Medisca VersaPro Cream Base | Diclofenac Sodium | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca VersaPro Cream Base | Testosterone | VersaPro Cream Base | |
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5% and Estriol 0.1-2% in Medisca VersaPro Cream Base | Estradiol, Estriol | VersaPro Cream Base | |
Stability Assessment of Compounded Bracketed Estriol 0.01-10% in Medisca VersaPro Cream Base | Estriol | VersaPro Cream Base | |